Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

Massimo Iavarone*, Federica Invernizzi, Carolin Czauderna, Marco Sanduzzi-Zamparelli, Sherrie Bhoori, Giuliana Amaddeo, Matteo A. Manini, Miguel F. López, Margarita Anders, Matthias Pinter, Maria J.B. Rodríguez, Mario R. Cristóbal, Gabriel A. Soteras, Federico Piñero, Gerda E. Villadsen, Arndt Weinmann, Gonzalo Crespo, Vincenzo Mazzaferro, Helene Regnault, Massimo De GiorgioMaria L. González-Diéguez, Maria F. Donato, Maria Varela, Marcus Alexander Wörns, Jordi Bruix, Pietro Lampertico, Maria Reig

*Corresponding author for this work
26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences